Blog

Photo of Manni Mohyuddin from www.mdedge.com

Jul 7, 2024, 17:38

Some myeloma updates by Manni Mohyuddin

Manni Mohyuddin shared on X:

“Thanks again to Medscape for the opportunity to write about some myeloma updates at ASCO24.

I focus on the return of belantamab, and the use of quads in newly diagnosed myeloma.

ASCO 2024: Treating Myeloma Just Got More Complicated.”

Source: Manni Mohyuddin/X

Dr. Manni Mohyuddin is an Assistant Professor at the Huntsman Cancer Institute, University of Utah, specializing in oncology. He is mainly interested in myeloma, supportive care, end-of-life management, and implementing cost-effective, evidence-based treatment strategies.

ASCO 2024 ASCO24 belantamab cancer cancer treatment Manni Mohyuddin Medscape multiple myeloma myeloma research myeloma updates newly diagnosed myeloma OncoDaily Oncology quads

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage